HORMONAL THERAPY

Product Details:

Letrozole Tablet is an oral hormonal therapy used primarily in the treatment of hormone receptor-positive breast cancer. It belongs to the class of aromatase inhibitors and works by lowering estrogen levels in the body, which helps slow or stop the growth of estrogen-dependent cancer cells.

• Active Ingredient: Letrozole

• Dosage Form: Tablet

• Drug Class: Aromatase inhibitor

• Route of Administration: Oral

• Hormone receptor-positive breast cancer in postmenopausal women

• Adjuvant therapy after surgery

• First-line treatment for advanced or metastatic breast cancer

Letrozole inhibits the enzyme aromatase, which converts androgens into estrogen. Reduced estrogen levels decrease stimulation of hormone-dependent breast cancer cells.

• Effective in slowing disease progression in estrogen receptor-positive breast cancer

• Oral, once-daily dosing for convenience

• Can be used as part of combination therapy or as maintenance therapy

• Usually taken once daily, with or without food

• Swallow tablets whole with water

• Dose and duration determined by the oncologist

• Store below 25°C

• Keep in a dry place and protect from light

• Keep out of reach of children

• Common side effects: hot flashes, joint pain, fatigue, bone loss, nausea

• Bone density monitoring may be recommended during long-term therapy

• Should be used under medical supervision

Product Details:

Letrozole 2.5 mg Tablet is an oral hormonal therapy used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to the class of aromatase inhibitors, which reduce estrogen production in the body.

• Active Ingredient: Letrozole

• Strength: 2.5 mg

• Dosage Form: Tablet

• Drug Class: Aromatase inhibitor

• Route of Administration: Oral

• Hormone receptor-positive breast cancer in postmenopausal women

• Adjuvant therapy after surgery to reduce the risk of cancer recurrence

• First-line treatment for advanced or metastatic hormone-sensitive breast cancer

Letrozole inhibits the enzyme aromatase, which converts androgens into estrogen. Lowering estrogen levels reduces stimulation of hormone-dependent breast cancer cells, slowing or stopping tumor growth.

• Effective in reducing recurrence in early breast cancer

• Convenient once-daily oral dosing

• Can be used alone or in combination with other therapies

• Usually taken once daily, with or without food

• Tablets should be swallowed whole with water

• Dose and duration determined by the treating oncologist

• Store below 25°C

• Keep in a dry place and protect from light

• Keep out of reach of children

• Common side effects: hot flashes, joint pain, fatigue, bone loss, nausea

• Bone density monitoring may be recommended during long-term therapy

• Should be used under medical supervision

Additional Information:

• Packaging Details: 10*10 STRIPS PER BOX

Product Details:

Letrozole 2.5 mg Tablet is an oral hormonal therapy used in the management of hormone receptor-positive breast cancer, particularly in postmenopausal women. It belongs to the class of aromatase inhibitors and works by reducing estrogen levels in the body.

• Active Ingredient: Letrozole

• Strength: 2.5 mg

• Dosage Form: Tablet

• Drug Class: Aromatase inhibitor

• Route of Administration: Oral

• Hormone receptor-positive breast cancer in postmenopausal women

• Adjuvant therapy after surgery to reduce the risk of recurrence

• First-line treatment for advanced or metastatic hormone-sensitive breast cancer

Letrozole inhibits the enzyme aromatase, which converts androgens to estrogen. By lowering estrogen levels, it reduces stimulation of hormone-dependent breast cancer cells, slowing tumor growth.

• Reduces the risk of cancer recurrence

• Convenient once-daily oral dosing

• Can be used alone or alongside other therapies

• Take once daily, with or without food

• Swallow tablets whole with water

• Dose and duration are determined by the treating physician

• Store below 25°C

• Keep in a dry, light-protected place

• Keep out of reach of children

• Common side effects: hot flashes, joint pain, fatigue, bone density loss, nausea

• Long-term use may require bone density monitoring

• Must be used under medical supervision